| | Business Summary | | Alaris
Medical,
Inc.,
a
holding
company
operating
through
its
consolidated
subsidiaries,
designs,
manufactures,
distributes
and
services
intravenous
infusion
therapy
and
patient
monitoring
instruments
and
related
disposables
and
accessories.
The
Company
is
a
provider
of
infusion
systems
and
related
technologies
to
the
United
States
hospital
market,
with
a
large
installed
base
of
pump
delivery
lines
(channels).
In
addition,
the
Company
is
a
provider
of
patient
monitoring
products
that
measure
and
monitor
temperature,
pulse,
pulse
oximetry
and
blood
pressure,
with
a
large
installed
base
of
hospital
thermometry
systems
in
the
United
States. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | AMI
through
its
major
operating
subsidiary,
ALARIS
Medical
Systems,
Inc.,
develops
and
manufactures
intravenous
infusion
pumps,
periodic
patient
monitoring
devices.
For
the
six
months
ended
6/30/01,
revenues
rose
8%
to
$197.4
million.
Net
loss
from
continuing
operations
rose
96%
to
$10.6
million.
Revenues
reflect
higher
sales
of
disposable
administration
sets.
Higher
loss
reflects
a
$6.9
million
restructuring
charge
and
increased
employee
benefits
expense. | | More
from
Market Guide: Significant
Developments |
| | | | FY2000 Pay | |
| Norman Dean, 81
Chairman | -- | David Schlotterbeck, 53
Pres,
CEO, Director | $540K | William Bopp, 57
Sr.
VP, CFO | 307K | Stuart Rickerson
VP,
Gen. Counsel, Sec. | -- | Frederic Denerolle, 41
VP
and Gen. Mang. of the International Bus. Unit. | -- | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/a/ami.gif)